Table 4.
Time of sampling (min) | Cut-off (µmol/l) | Disease present | Disease absent | Sp (%) | Se (%) | NPV (%) | PPV (%) |
---|---|---|---|---|---|---|---|
95% CI | 95% CI | 95% CI | 95% CI | ||||
45 | 4.61 | 59 | 42 | 50.0 | 74.6 | 58.3 | 67.7 |
34–66 | 62–85 | 41–75 | 55–79 | ||||
90 | 5.87 | 59 | 42 | 52.4 | 76.3 | 61.1 | 69.2 |
36–68 | 63–86 | 44–77 | 57–80 |
CSL clinically significant lesions, Se sensitivity, Sp specificity, NPV negative predictive value, PPV positive predictive value, 95% CI 95% confidence intervals